Medical Marijuana's Potential Therapeutic Value | cannabisMD

Medical Marijuana’s Potential Therapeutic Value

therapeutic potential of medical marijuana

Cannabinoids are situated in the marijuana plant (cannabis sativa) and are deemed to be great in the regulation of pain in symptoms such as irritable bowel syndrome and cancer. A cannabinoid is one in a group of a wide variety of chemical compounds that are endogenous and are allowed to bind to major cannabinoid receptors in cells that controls neurotransmitter expulsion at nueronal sites. The endogenous cannabinoid system, that occurs in the body by animals, allows plant cannabinoids and synthetic cannabinoids to work in the body. The major endogenous cannabinoid is tetrahydrocannabinol (THC), the main psychoactive compound in marijuana. Cannabidiol (CBD) is another main chemical of the cannabis plant and manufactures a non psychotic anti inflammatory effect. Cannabinoids surely have a therapeutic possibility, however they haven’t been looked into properly yet so that they can cure a collection of human diseases. This paper will evaluate cannabinoids and their therapeutic implications in medicine.

Here is the full scientific article if you wish to download it.

Main Points

  • Cannabinoids may be used to chronic pain
  • Cannabinoids and their therapeutic potential

Cannabinoids may be used to chronic pain

The application of marijuana for medicinal reasons is undeniably rooted through the past, dating back to prehistoric times. It once cradled a prominent role in the history of medicine, advocated by plenty of eminent physicians for several disorders specifically headache and migraine. Through the years, this plant has embarked on an amazing quest from a legal and often prescribed role to illegal, driven by political and social conditions rather than by science. However, with a great amount of developing push for its multitude of medicinal applications, the uninformed stigma of marijuana is slowly disappearing, and there has been extensive support for legalizing medicinal marijuana and study. Almost half of America has now legalized medicinal marijuana, numerous states have legalized recreational application, and others have legalized CBD, which is one of many therapeutic cannabinoids taken from cannabis. Physicians need to be better informed on the history, pharmacology, clinical suggestions, and proper clinical use of marijuana, as people will inevitably want to know about it for many disorders, including chronic pain and headache syndromes for which there is some interesting supportive evidence.

Cannabinoids and their therapeutic potential

The relevance of sterility and plausible adverse events from non‐sterile growing cultures is illustrated by a study of allergic bronchopulmonary aspergillosis because of microbial contamination from smoking moldy marijuana. These changes will be very detrimental in further research, as there seemed to be at least 100 various types of plant cannabinoids, and only a few of them have been investigated and reviewed. Some give off psychoactive adverse events, while others have no psychoactive adverse events, as talked about here. Therefore, these seen adverse events are based on solely non‐standardized reviews, the same as many of the anecdotal and case‐based reports indicating benefit. This is synonymous to reviewing side effects in a random mixture of the widely variable antidepressant prescriptions, and then lumping all reported side effects into similar adverse effect faces for antidepressants as a general group. However, in reality, it is seen that various antidepressants have different pharmacologic abilities and side effects. Marijuana application as a prescription should be thought of no differently. Therefore, these seen adverse events should not be looked at to be universal marijuana adverse events, but need to be more appropriately correlated with selective plant cannabinoids, plant cannabinoid ratios, and the aforementioned variables as medical studies ventures forward. This is critical for evaluating adverse adverse events, as well as analgesic benefits.

Jonathan Neilly
Jonathan Neilly
Jonathan Neilly is registered with the British Psychological Society, breaking the taboo on mental health issues is one of the driving forces in his life. His background in biomedicine gives him additional understanding of the factors that work together to influence the human condition.

Leave a Reply

Your email address will not be published. Required fields are marked *